Pharmacological inhibition from the ataxia telangiectasia and Rad3-associated protein serine/threonine kinase (ATR; also called FRAP-associated protein (FRP1)) has emerged to be a promising approach for most cancers procedure that exploits synthetic lethal interactions with proteins linked to DNA hurt restore, overcomes resistance to other therapies and boosts antitumour immunity. A https://eddiey110itd2.ouyawiki.com/user